F. Lodi

发表

Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization

Y. Saeys, D. Lambrechts, O. De Wever, 2021, Nature Neuroscience.

GBM tumors are heterogeneous in their fatty acid metabolism and modulating fatty acid metabolism sensitizes cancer cells derived from recurring GBM tumors to temozolomide

D. Lambrechts, R. Sciot, G. Bergers, 2022, Frontiers in Oncology.

Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer.

A. Bardelli, L. Trusolino, A. Bertotti, 2018, Cancer cell.

Identification, validation and biological characterization of novel Glioblastoma Tumour Microenvironment subtypes: Implications for precision immunotherapy.

R. Verhaak, P. Wen, M. Lamfers, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

BCAT1 inhibition affects CD8+ T cell activation, exhaustion, and tumoral immunity by altering iron homeostasis

Charles D. Yeh, D. Lambrechts, Kwon-Sik Park, 2023, bioRxiv.

Targeting the RhoGEF βPIX/COOL-1 in Glioblastoma: Proof of Concept Studies

J. Sarkaria, D. Lambrechts, R. Schiffelers, 2020, Cancers.

Tumor endothelial cell autophagy is a key vascular‐immune checkpoint in melanoma

M. Bertrand, D. Lambrechts, L. Boon, 2023, bioRxiv.

Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers

M. J. van den Bent, D. Lambrechts, A. Kleijn, 2023, British Journal of Cancer.

Identification of inter- and intra-tumoral molecular phenotypes steering temozolomide resistance in patient-derived glioblastoma cells

D. Lambrechts, M. Lamfers, S. Leenstra, 2023, bioRxiv.

Comparative analysis of deeply phenotyped GBM cohorts of ‘short-term’ and ‘long-term’ survivors

D. Lambrechts, M. Lamfers, S. Leenstra, 2023, Journal of Neuro-Oncology.

Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer.

A. Bardelli, L. Trusolino, A. Bertotti, 2018, Cancer cell.

Genomic Exploration of Distinct Molecular Phenotypes Steering Temozolomide Resistance Development in Patient-Derived Glioblastoma Cells

D. Lambrechts, M. Lamfers, S. Leenstra, 2023, International journal of molecular sciences.

Identification, validation and biological characterization of novel Glioblastoma Tumour Microenvironment subtypes: Implications for precision immunotherapy.

A. Idbaih, C. Sautès-Fridman, A. Bougoüin, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

PD-1- CD45RA+ effector-memory CD8 T cells and CXCL10+ macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma

D. Lambrechts, B. Boeckx, A. Bassez, 2023, Nature communications.

Single-cell Atlas of Penile Cancer Reveals TP53 Mutations as a Driver of an Aggressive Phenotype, Irrespective of Human Papillomavirus Status, and Provides Clues for Treatment Personalization.

D. Lambrechts, S. Mohanty, A. Bassez, 2024, European urology.